TY - T1 - Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score SN - / UR - http://hdl.handle.net/10138/315923 T3 - A1 - Tesch, Victoria Katharina; Abolhassani, Hassan; Shadur, Bella; Zobel, Joachim; Mareika, Yuliya; Sharapova, Svetlana; Karakoc-Aydiner, Elif; Rivière, Jacques G.; Garcia-Prat, Marina; Moes, Nicolette; Haerynck, Filomeen; Gonzales-Granado, Luis I.; Santos Pérez, Juan Luis; Mukhina, Anna; Shcherbina, Anna; Aghamohammadi, Asghar; Hammarström, Lennart; Dogu, Figen; Haskologlu, Sule; İkincioğulları, Aydan İ.; Köstel Bal, Sevgi; Baris, Safa; Kilic, Sara Sebnem; Karaca, Neslihan Edeer; Kutukculer, Necil; Girschick, Hermann; Kolios, Antonios; Keles, Sevgi; Uygun, Vedat; Stepensky, Polina; Worth, Austen; van Montfrans, Joris M.; Peters, Anke M.J.; Meyts, Isabelle; Adeli, Mehdi; Marzollo, Antonio; Padem, Nurcicek; Khojah, Amer M.; Chavoshzadeh, Zahra; Avbelj Stefanija, Magdalena; Bakhtiar, Shahrzad; Florkin, Benoit; Meeths, Marie; Gamez, Laura; Grimbacher, Bodo; Seppänen, Mikko R.J.; Lankester, Arjan; Gennery, Andrew R.; Seidel, Markus G. A2 - PB - Y1 - 2020 LA - eng AB - Background Recent findings strongly support hematopoietic stem cell transplantation (HSCT) in patients with severe presentation of LPS-responsive beige-like anchor protein (LRBA) deficiency, but long-term follow-up and survival data beyond previous patient reports or meta-reviews are scarce for those patients who do not receive a transplant. Objective This international retrospective study was conducted to elucidate the longitudinal clinical course of patients with LRBA deficiency who do and do ... VO - IS - SP - OP - KW - Inborn error of immunity; primary immunodeficiency disorder; immune dysregulation; clinical score; performance scale; hematopoietic stem cell transplantation; CTLA4; abatacept; sirolimus; combined immunodeficiency; 3121 General medicine, internal medicine and other clinical medicine N1 - PP - ER -